视黄酸依赖Fas/RARa融合基因转导靶细胞启动的细胞自杀效应研究
批准号:
39970321
项目类别:
面上项目
资助金额:
12.0 万元
负责人:
糜漫天
依托单位:
学科分类:
白细胞与相关疾病
结题年份:
2002
批准年份:
1999
项目状态:
已结题
项目参与者:
糜漫天、徐访潜、黄继明、杨志祥、周东明、郎海滨、韦娜、袁家林
关键词:
中文摘要
通过构建含Fas抗原“死亡区”和视黄酸核受体RAR配体结合区的融合基因表达载体,使该基因表达受控于视黄酸反应元件(RARE)相连的TK启动子,将Fas/RARa融合基因转导入耐药早幼粒白血病细胞内,进而用视黄酸启动配体依赖细胞自杀机制,清除诱导分化治疗耐药的抗性细胞。该项目在于采用一全新的基因治疗策略有效解决肿瘤诱导分化治疗中的耐药问题。
英文摘要
In this paper, we constructed a novel expression vector of fusion gene Fas/RAR alpha containing RARE-TK promoter and reporter gene eGFP controlled by ATRA and observed the effect of apoptosis initiated by fusion protein Fas/RAR alpha after transfection to HL-60 and MCF-7 malignant cells. The results and conclusions are summarized as follows: 1) The reporter gene plasmid containing RARE (pRARE3-TK-eGFP) was transfected into HL-60 cells. After treatment with ATRA, the expression of eGFP was detected by fluorescence microscopy and RT-PCR. Treatment of transfected HL-60 cells with RA for scheduled times resulted in obvious increase of eGFP in RA dependent manner. These findings suggested that RA is able to induce the expression of exogenous gene under RARE-TK promoter. 2) The fusion gene vector (pRARE-Fas/RAR alpha) containing RARE-TK promoter and eGFP was constructed and transfected to HL-60 and MCF-7 cells. Transfected cells were treated with RA for 24h, 48h, and 72h respectively, as compared with nontransfected ones treated with RA at the same time. The expression of reporter gene (fusion gene) in pRARE-Fas/RAR alpha transfected cells stimulated with RA was higher than that in control group. And it was found that the fusion protein Fas/RAR alpha was mainly located in cell membrane. 3) The proliferation capacity was decreased, the apoptotic rate and the DNA fragmentation rate were increased in cells treated by RA. The DNA ladder was detectable in RA-treated cells. The morphological apoptosis changes were observed by transmission electron microscopy and TUNEL detection. These changes were more obviously in pRARE-Fas/RAR alpha transfected cells than nontransfected cells. Our study demonstrated that RA and the product of exogenous fusion gene induced by RA could cooperate in inhibition of cell growth and inducing apoptosis.4) The expressions of caspase-8 and caspase-3 genes were increased in tumor cells treated with RA. The expression of active subunit protein of caspase-3 was increased in HL-60 cells treated with RA. These changes were more obvious in transfected cells than nontransfected cells. Our study suggested that up-regulated expression and activity of several caspases may be play a key role in RA and fusion gene inducing apoptosis..The results above are helpful to find the optimal strategies to overcome the resistance to RA and decrease ill effects in clinical use of RA. .
基于“HIF-1α-表观元控组-IFN-γ/TRAIL”途径研究肝脏ILC1介导的区域免疫调节在高脂诱导的代谢紊乱及MAFLD发生发展中的作用
-
批准号:82173506
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:糜漫天
-
依托单位:
二氢杨梅素通过SIRT3-H3K27ac-IL22轴促进肠粘膜固有层ILC3免疫功能和维持肠粘膜屏障防治T2DM的作用及机制研究
-
批准号:81973039
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:糜漫天
-
依托单位:
辣椒素通过调节肠道菌群-胆汁酸轴防治2型糖尿病的作用与机制研究
-
批准号:81673157
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2016
-
负责人:糜漫天
-
依托单位:
基于肠道菌群为靶点的白藜芦醇调控TMAO代谢转化及抗动脉粥样硬化作用研究
-
批准号:81470562
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2014
-
负责人:糜漫天
-
依托单位:
白藜芦醇在血管内皮细胞的生物利用特点及损伤保护效应研究
-
批准号:81172670
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:糜漫天
-
依托单位:
大豆甙元干预对不同雌马酚代谢表型高胆固醇血症人群防治效应研究
-
批准号:81072288
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2010
-
负责人:糜漫天
-
依托单位:
细胞氧化还原状态改变在植物黄酮抗肿瘤机制中的作用研究
-
批准号:30671754
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:糜漫天
-
依托单位:
1,25二羟维生素D3 靶控ER基因导入联合他莫昔芬对表型转化ER阴性乳腺癌细胞的效应研究
-
批准号:30371217
-
项目类别:面上项目
-
资助金额:21.0万元
-
批准年份:2003
-
负责人:糜漫天
-
依托单位:
胆固醇合成抑制剂对高表达BRCA1基因乳腺癌细胞增殖影响
-
批准号:30271128
-
项目类别:面上项目
-
资助金额:21.0万元
-
批准年份:2002
-
负责人:糜漫天
-
依托单位:
视黄酸对带CRABPⅡ启动子IFN表达载体转染细胞诱导分化
-
批准号:39770303
-
项目类别:面上项目
-
资助金额:12.0万元
-
批准年份:1997
-
负责人:糜漫天
-
依托单位:
P34CDK2蛋白在视黄酸阻遏白血病细胞增殖中作用的研究
-
批准号:39570296
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:1995
-
负责人:糜漫天
-
依托单位:
国内基金
海外基金